Barclays Lowers its Price Target on Hims & Hers Health, Inc. (HIMS) to $25 and Keeps an Overweight Rating
Business
Archived
•
March 5, 2026
•
Source: https://finance.yahoo.com/rss/topstories - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"Free Quote Today"